Mohamed Bouattour

17PUBLICATIONS
119CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyLiquid biopsiesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Apr 20, 2026
Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

|Oct 17, 2025
Correction: ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view.

Mohamed Bouattour, Valérie Vilgrain, Mickaël Lesurtel

|Jul 09, 2025
Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial.

Louis Gros, Mohamed Bouattour, Clément Dumont

|Jun 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Jean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier

|May 09, 2025
ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view.

Mohamed Bouattour, Valérie Vilgrain, Mickaël Lesurtel

Pageof 3

Frequent Collaborators

3 joint publications

Jean-Charles Nault

2 joint publications

Katharina Pomej

2 joint publications

Maxime Ronot

2 joint publications

Thomas Reiberger